BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14660098)

  • 1. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.
    Lopez-Beltran A; Cheng L
    Pathology; 2003 Dec; 35(6):484-91. PubMed ID: 14660098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications.
    Jimenez RE; Keane TE; Hardy HT; Amin MB
    Adv Anat Pathol; 2000 Jan; 7(1):13-25. PubMed ID: 10640198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pussycats and baby tigers: non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same!
    Sauter G; Mihatsch MJ
    J Pathol; 1998 Aug; 185(4):339-41. PubMed ID: 9828830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage T1 bladder cancer: diagnostic criteria and pitfalls.
    Lopez-Beltran A; Cheng L
    Pathology; 2021 Jan; 53(1):67-85. PubMed ID: 33153725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
    Mhawech-Fauceglia P; Ali L; Cheney RT; Groth J; Herrmann FR
    J Clin Pathol; 2009 Aug; 62(8):710-4. PubMed ID: 19638542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
    Raspollini MR; Montironi R; Mazzucchelli R; Cimadamore A; Cheng L; Lopez-Beltran A
    Virchows Arch; 2020 Jul; 477(1):3-16. PubMed ID: 32296929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth pattern in superficial urothelial bladder carcinomas. Histological review and clinical relevance.
    López JI; Angulo JC
    Int Urol Nephrol; 2009 Dec; 41(4):847-54. PubMed ID: 19283508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.
    van der Aa MN; van Leenders GJ; Steyerberg EW; van Rhijn BW; Jöbsis AC; Zwarthoff EC; van der Kwast TH
    Hum Pathol; 2005 Sep; 36(9):981-6. PubMed ID: 16153461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological variants of invasive bladder cancer according to their suggested clinical significance.
    Lopez-Beltran A; Requena MJ; Cheng L; Montironi R
    BJU Int; 2008 Feb; 101(3):275-81. PubMed ID: 17986288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.